Wolverine Trading, LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $14.1 Million - $16.6 Million	13,800 Added 54.76%	39,000 $41 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $5.65 Million - $6.86 Million	6,400 Added 34.04%	25,200 $26.5 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $3.34 Million - $3.68 Million	-3,700 Reduced 16.44%	18,800 $18.1 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $2.4 Million - $2.73 Million	3,100 Added 15.98%	22,500 $19.8 Million
Q3 2023 Nov 15, 2023	SELL	$692.45 - $844.37 $16.2 Million - $19.8 Million	-23,400 Reduced 54.67%	19,400 $16 Million
Q2 2023 Aug 23, 2023	BUY	$700.03 - $830.35 $30 Million - $35.5 Million	42,800 New	42,800 $30.8 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $2.18 Million - $2.75 Million	3,800 Added 19.59%	23,200 $16.1 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $2.47 Million - $3.32 Million	4,500 Added 30.2%	19,400 $11.6 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $9.64 Million - $11.3 Million	-16,200 Reduced 52.09%	14,900 $10.3 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $5.11 Million - $6.31 Million	-9,400 Reduced 23.21%	31,100 $20 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $459,224 - $544,768	800 Added 2.02%	40,500 $24.6 Million
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $4.35 Million - $5.14 Million	9,200 Added 30.16%	39,700 $21.7 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $28 Million - $34.3 Million	-62,600 Reduced 67.24%	30,500 $14.4 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $18.1 Million - $23 Million	37,900 Added 68.66%	93,100 $44.5 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $3.54 Million - $4.28 Million	-6,500 Reduced 10.53%	55,200 $31.7 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $30.4 Million - $39.7 Million	61,700 New	61,700 $37.7 Million
Q1 2020 May 11, 2020	SELL	$336.18 - $494.43 $33 Million - $48.6 Million	-98,300 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $1.45 Million - $2 Million	-5,300 Reduced 5.12%	98,300 $36.7 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $28.3 Million - $33 Million	103,600 New	103,600 $28.3 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $22.9 Million - $27.1 Million	-61,600 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $2.22 Million - $2.66 Million	6,600 Added 12.0%	61,600 $22.3 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $1.02 Million - $1.18 Million	-2,900 Reduced 5.01%	55,000 $22.2 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $8.37 Million - $10.4 Million	-26,500 Reduced 31.4%	57,900 $19.9 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $3.12 Million - $4.09 Million	8,700 Added 11.49%	84,400 $31.7 Million
Q3 2017 Nov 15, 2017	BUY	$431.38 - $504.0 $32.7 Million - $38.2 Million	75,700	75,700 $33.8 Million

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account